SCHEMBL6540192

SCHEMBL6540192

COc1ccc(-c2[nH]c(=S)oc2-c2ccc(OCc3ccccc3)cc2)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
PABPC1 P11940 1/20 0.47
MAPT P10636 4/20 0.41
PTGES O14684 3/20 0.41
HSD17B10 Q99714 2/20 0.41
LMNA P02545 2/20 0.41
PRMT5 O14744 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GRM5 P41594 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
ALOX5 P09917 1/20 0.41
LTC4S Q16873 1/20 0.41
MAPK1 P28482 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6540444 0.85 RCE1 (0.45) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL6539010 0.74 PPARD (0.50) MEN1KMT2APABPC1MAPTLMNA
SCHEMBL6538986 0.74 MEN1 (0.46) MEN1KMT2APABPC1MAPTHSD17B10
SCHEMBL6231211 0.74 MEN1 (0.48) MEN1KMT2APABPC1MAPTHSD17B10
SCHEMBL9950591 0.73 MEN1 (0.63) MEN1KMT2APABPC1MAPTLMNA
SCHEMBL6539086 0.73 MEN1 (0.45) MEN1KMT2APABPC1MAPTHSD17B10
SCHEMBL6539132 0.73 MEN1 (0.45) MEN1KMT2APABPC1MAPTHSD17B10
SCHEMBL6539387 0.73 PPARD (0.47) MEN1KMT2APABPC1MAPTHSD17B10
SCHEMBL6208143 0.73 MEN1 (0.53) MEN1KMT2APABPC1GRM5ACACB
SCHEMBL6538871 0.73 MAOB (0.47) MEN1KMT2AMAPTPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 MEN1 4420/4885KMT2A 3081/4885PABPC1 2765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.